Health
FDA approval adds an antibody option for infants’ first RSV season
Enflonsia’s June 2025 approval followed trials evaluating prevention of lower respiratory tract disease.
IN FOCUS
IN FOCUS
Enflonsia’s June 2025 approval followed trials evaluating prevention of lower respiratory tract disease.